L
L. Jeffrey Medeiros
Researcher at University of Texas MD Anderson Cancer Center
Publications - 1208
Citations - 42760
L. Jeffrey Medeiros is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Lymphoma & Myeloid leukemia. The author has an hindex of 93, co-authored 1120 publications receiving 37333 citations. Previous affiliations of L. Jeffrey Medeiros include City of Hope National Medical Center & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
The Heidelberg classification of renal cell tumours
Gyula Kovacs,Mohammed Akhtar,Bruce Beckwith,Peter Bugert,Colin Cooper,Brett Delahunt,John N. Eble,Stewart Fleming,Börje Ljungberg,L. Jeffrey Medeiros,Holger Moch,Victor E. Reuter,Eberhard Ritz,Göran Roos,Dietmar Schmidt,John R. Srigley,Stephan Störkel,Eva van den Berg,Bert Zbar +18 more
TL;DR: This paper presents the conclusions of a workshop entitled ‘Impact of Molecular Genetics on the Classification of Renal Cell Tumours’, which was held in Heidelberg in October 1996 and is applicable to routine diagnostic practice.
Book ChapterDOI
Mantle Cell Lymphoma
TL;DR: Mantle cell lymphoma (MCL) is a B-cell neoplasm thought to derive from mantle zone B-cells and characterized by translocations involving the CCND1 gene, most commonly t(11,14),q13,q23 as discussed by the authors.
Journal ArticleDOI
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
Shimin Hu,Zijun Y. Xu-Monette,Alexander Tzankov,Tina Green,Lin Wu,Aarthi Balasubramanyam,Wei-Min Liu,Carlo Visco,Yong Li,Roberto N. Miranda,Santiago Montes-Moreno,Karen Dybkær,April Chiu,Attilio Orazi,Youli Zu,Govind Bhagat,Kristy L. Richards,Eric D. Hsi,William W.L. Choi,Xiaoying Zhao,J. Han van Krieken,Qin Huang,Jooryung Huh,Weiyun Z. Ai,Maurilio Ponzoni,Andrés J.M. Ferreri,Fan Zhou,Graham W. Slack,Randy D. Gascoyne,Meifeng Tu,Daina Variakojis,Weina Chen,Ronald S. Go,Miguel A. Piris,Michael Boe Møller,L. Jeffrey Medeiros,Ken H. Young +36 more
TL;DR: It is concluded that MYC/BCL2 coexpression in DLBCL is associated with an aggressive clinical course, is more common in the ABC subtype, and contributes to the overall inferior prognosis of patients with ABC-DLBCL.
Journal ArticleDOI
High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine
Jorge E. Romaguera,Luis Fayad,Maria A Rodriguez,Kristine Broglio,Frederick B. Hagemeister,Barbara Pro,Peter McLaughlin,Anas Younes,Felipe Samaniego,Andre Goy,Andreas H. Sarris,Nam H. Dang,Michael Wang,Virginia Beasley,L. Jeffrey Medeiros,Ruth L. Katz,Harish Gagneja,Barry I. Samuels,Terry L. Smith,Fernando Cabanillas +19 more
TL;DR: Rituximab plus hyper-CVAD alternating with rituxIMab plus high-dose methotrexate and cytarabine is effective in untreated aggressive MCL and toxicity is significant but expected.
Journal ArticleDOI
Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients
Roberto N. Miranda,Tariq N. Aladily,H. Miles Prince,Rashmi Kanagal-Shamanna,Daphne de Jong,Luis Fayad,Mitual Amin,Nisreen Haideri,Govind Bhagat,Glen S. Brooks,David A. Shifrin,Dennis P. O'Malley,Chan Yoon Cheah,Carlos E. Bacchi,Gabriela Gualco,Shiyong Li,John A. Keech,Ephram P. Hochberg,Matthew J. Carty,Summer E. Hanson,Eid Mustafa,Steven Sanchez,John T. Manning,Zijun Y. Xu-Monette,Alonso R. Miranda,Patricia S. Fox,Roland L. Bassett,Jorge J. Castillo,Brady E Beltran,Jan de Boer,Zaher Chakhachiro,Dongjiu Ye,Douglas P. Clark,Ken H. Young,L. Jeffrey Medeiros +34 more
TL;DR: Most patients with breast implant-associated ALCL who had disease confined within the fibrous capsule achieved complete remission, justifying cytotoxic chemotherapy in addition to removal of implants.